Next Article in Journal
Design, Synthesis and Biological Evaluation of New 5,5-Diarylhydantoin Derivatives as Selective Cyclooxygenase-2 Inhibitors
Previous Article in Journal
Neglected Disease – African Sleeping Sickness: Recent Synthetic and Modeling Advances
Article Menu

Article Versions

Export Article

Open AccessArticle
Sci. Pharm. 2011, 79(3), 429-448; doi:10.3797/scipharm.1103-16

Design, Synthesis and Biological Evaluation of Novel Pyrimido[4,5-d]pyrimidine CDK2 Inhibitors as Anti-Tumor Agents

1
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt
2
Department of Organic Chemistry, National Organization for Drug Control and Research, P.O. Box 29, Cairo, Giza 12311, Egypt
3
Pharmaceutical Chemistry Department, Faculty of Pharmacy, Misr International University, Km 28 Cairo-Ismailia Road, Cairo, Egypt
*
Author to whom correspondence should be addressed.
Received: 23 March 2011 / Accepted: 8 May 2011 / Published: 8 May 2011
Download PDF [583 KB, uploaded 28 September 2016]

Abstract

A series of 2,5,7-trisubstituted pyrimido[4,5-d]pyrimidine cyclin-dependent kinase (CDK2) inhibitors is designed and synthesized. 6-Amino-2-thiouracil is reacted with an aldehyde and thiourea to prepare the pyrimido[4,5-d]-pyrimidines. Alkylation and amination of the latter ones give different amino derivatives. These compounds show potent and selective CDK inhibitory activities and inhibit in vitro cellular proliferation in cultured human tumor cells.
Keywords: Drug Design; Pharmacophore; Pyrimido[4,5-d]pyrimidine; CDK2; Anti-tumor Drug Design; Pharmacophore; Pyrimido[4,5-d]pyrimidine; CDK2; Anti-tumor
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

EL-MOGHAZY, S.M.; IBRAHIM, D.A.; ABDELGAWAD, N.M.; FARAG, N.A.H.; EL-KHOULY, A.S. Design, Synthesis and Biological Evaluation of Novel Pyrimido[4,5-d]pyrimidine CDK2 Inhibitors as Anti-Tumor Agents. Sci. Pharm. 2011, 79, 429-448.

Show more citation formats Show less citations formats

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Sci. Pharm. EISSN 2218-0532 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top